help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Molecular Endocrinology, doi:10.1210/me.2003-0082
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, B. W.
Right arrow Articles by Bianco, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, B. W.
Right arrow Articles by Bianco, A. C.
Molecular Endocrinology 17 (12): 2603-2612
Copyright © 2003 by The Endocrine Society

Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2

Brian W. Kim, Ann M. Zavacki, Cyntia Curcio-Morelli, Monica Dentice, John W. Harney, P. Reed Larsen and Antonio C. Bianco

Thyroid Section, Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital and Harvard Medical School

Address all correspondence and requests for reprints to: Antonio C. Bianco, M.D., Ph.D., Brigham and Women’s Hospital; HIM Building, Room 566, 77 Louis Pasteur Avenue, Boston, Massachusetts 02115. E-mail: abianco{at}partners.org.

The type 2 iodothyronine selenodeiodinase (D2) is an endoplasmic reticulum (ER)-resident selenoprotein that activates T4 to T3, playing a critical role in thyroid homeostasis. D2 has an approximately 45-min half-life due to selective ubiquitin-mediated ER-associated degradation (ERAD), a process of particular interest because it is accelerated by exposure to D2 substrates, T4 or rT3. The present in vitro binding studies indicate that glutathione-S-transferase (GST)-human D2 fusion proteins specifically associate with a mammalian homolog of the ubiquitin conjugase UBC7 (MmUBC7), with localization to amino acids 169–234 of D2. Coexpression of D2 with an inactive D2 mutant or a truncated version containing amino acids 169–234 stabilizes D2 half-life, supporting the importance of the carboxyl region of D2 for ERAD. Mammalian UBC6 (MmUBC6) does not directly associate with D2 but can associate with a complex containing UBC7 and D2. At the same time, functional studies in human embryonic kidney-293 cells indicate that D2 activity half-life and protein levels are stabilized only when inactive mutants of both UBC6 and UBC7 are overexpressed with D2, suggesting that redundancy may exist at the level of the E2 for both basal and substrate-accelerated D2 ERAD. In conclusion, D2 ERAD in human cells proceeds via an association between UBC7 and the carboxyl region of D2, a unique mechanism for the control of thyroid hormone activation.




This article has been cited by other articles:


Home page
 Mol. Cell. Biol.Home page
A. M. Zavacki, R. Arrojo e Drigo, B. C. G. Freitas, M. Chung, J. W. Harney, P. Egri, G. Wittmann, C. Fekete, B. Gereben, and A. C. Bianco
The E3 Ubiquitin Ligase TEB4 Mediates Degradation of Type 2 Iodothyronine Deiodinase
Mol. Cell. Biol., October 1, 2009; 29(19): 5339 - 5347.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling
Endocr. Rev., December 1, 2008; 29(7): 898 - 938.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
F. S. Celi, G. Coppotelli, A. Chidakel, M. Kelly, B. A. Brillante, T. Shawker, N. Cherman, P. P. Feuillan, and M. T. Collins
The Role of Type 1 and Type 2 5'-Deiodinase in the Pathophysiology of the 3,5,3'-Triiodothyronine Toxicosis of McCune-Albright Syndrome
J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2383 - 2389.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. Lamirand, G. Mercier, M. Ramauge, M. Pierre, and F. Courtin
Hypoxia Stabilizes Type 2 Deiodinase Activity in Rat Astrocytes
Endocrinology, October 1, 2007; 148(10): 4745 - 4753.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Fekete, B. C. G. Freitas, A. Zeold, G. Wittmann, A. Kadar, Z. Liposits, M. A. Christoffolete, P. Singru, R. M. Lechan, A. C. Bianco, et al.
Expression Patterns of WSB-1 and USP-33 Underlie Cell-Specific Posttranslational Control of Type 2 Deiodinase in the Rat Brain
Endocrinology, October 1, 2007; 148(10): 4865 - 4874.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
G. D. V. Sagar, B. Gereben, I. Callebaut, J.-P. Mornon, A. Zeold, W. S. da Silva, C. Luongo, M. Dentice, S. M. Tente, B. C. G. Freitas, et al.
Ubiquitination-Induced Conformational Change within the Deiodinase Dimer Is a Switch Regulating Enzyme Activity
Mol. Cell. Biol., July 1, 2007; 27(13): 4774 - 4783.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
A. Zeold, L. Pormuller, M. Dentice, J. W. Harney, C. Curcio-Morelli, S. M. Tente, A. C. Bianco, and B. Gereben
Metabolic Instability of Type 2 Deiodinase Is Transferable To Stable Proteins Independently of Subcellular Localization
J. Biol. Chem., October 20, 2006; 281(42): 31538 - 31543.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. S. Oh, X. Bai, and J. M. Rommens
Human Homologs of Ubc6p Ubiquitin-conjugating Enzyme and Phosphorylation of HsUbc6e in Response to Endoplasmic Reticulum Stress
J. Biol. Chem., July 28, 2006; 281(30): 21480 - 21490.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. D. Bhanumathy, S. K. Nakao, and S. K. Joseph
Mechanism of Proteasomal Degradation of Inositol Trisphosphate Receptors in CHO-K1 Cells
J. Biol. Chem., February 10, 2006; 281(6): 3722 - 3730.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Chen, J. Mariano, Y. C. Tsai, A. H. Chan, M. Cohen, and A. M. Weissman
The activity of a human endoplasmic reticulum-associated degradation E3, gp78, requires its Cue domain, RING finger, and an E2-binding site
PNAS, January 10, 2006; 103(2): 341 - 346.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
S. Yasuo, N. Nakao, S. Ohkura, M. Iigo, S. Hagiwara, A. Goto, H. Ando, T. Yamamura, M. Watanabe, T. Watanabe, et al.
Long-Day Suppressed Expression of Type 2 Deiodinase Gene in the Mediobasal Hypothalamus of the Saanen Goat, a Short-Day Breeder: Implication for Seasonal Window of Thyroid Hormone Action on Reproductive Neuroendocrine Axis
Endocrinology, January 1, 2006; 147(1): 432 - 440.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. P. Peeters, S. van der Geyten, P. J. Wouters, V. M. Darras, H. van Toor, E. Kaptein, T. J. Visser, and G. Van den Berghe
Tissue Thyroid Hormone Levels in Critical Illness
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6498 - 6507.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. H. A. Gouveia, M. A. Christoffolete, C. R. Zaitune, J. M. Dora, J. W. Harney, A. L. Maia, and A. C. Bianco
Type 2 Iodothyronine Selenodeiodinase Is Expressed throughout the Mouse Skeleton and in the MC3T3-E1 Mouse Osteoblastic Cell Line during Differentiation
Endocrinology, January 1, 2005; 146(1): 195 - 200.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society